Policy and Programmatic Considerations for Introduction of a Longer-Acting Injectable Contraceptive: Perspectives from International Opinion Leaders and Providers, Program Implementers, and Policymakers in Kenya and Rwanda

4256.0
Long acting reversible contraceptive methods

Tuesday, November 18, 2014: 12:30 PM - 2:00 PM

Oral

Moderator:

Heike Thiel de Bocanegra, Ph.D., M.P.H.

12:30pm

Access to long-acting reversible contraception for nulliparous women: Results from a cluster randomized trial
Susannah Gibbs, MSPH, Corinne Rocca, PhD, MPH, Kirsten M.J. Thompson, MPH, Philip Darney, MD, MSc, Paula Bednarek, MD, MPH, J. Joseph Speidel, MD, MPH and Cynthia C. Harper, PhD

12:45pm

1:00pm

Strategies to Improve Access to LARC: Focus on Advocacy for Appropriate Reimbursement
Alicia Luchowski, MPH and Myra Batchelder, MPA

1:15pm

Increasing Access to Long-Acting Reversible Contraception Yields Significant Results in Colorado
Kari Kuka, M.S. CHES, Tara Thomas-Gale, MPH and Greta Klingler, MPH CHES

1:30pm

See individual abstracts for presenting author's disclosure statement and author's information.

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)